MedTrace Logo

Blood Loss at the Time of First Trimester Surgical Abortion in Anticoagulated Women

NCT00614432 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 10

Last updated 2022-07-18

Study results available
· View outcomes & findings →

Summary

The primary objective of this study is to compare blood loss resulting from surgical termination of pregnancy up to 12 weeks gestation between women who are anticoagulated to therapeutic levels and those who are not anticoagulated. This study is based on the hypothesis that anticoagulant therapy does not increase intraoperative blood loss in women receiving surgical abortions up to 12 weeks gestation.

Conditions

  • Blood Loss

Sponsors & Collaborators

  • Oregon Health and Science University

    collaborator OTHER

  • University of Hawaii

    lead OTHER

Principal Investigators

  • Bliss Kaneshiro, M.D. · University of Hawaii

  • Alison Edelman, M.D., M.P.H. · Oregon Health and Science University

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-01-31
Primary Completion
2010-04-30
Completion
2010-04-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00614432 on ClinicalTrials.gov